TY - JOUR
T1 - Macrolides from rare actinomycetes
T2 - Structures and bioactivities
AU - Al-fadhli, Ammar A.
AU - Threadgill, Michael D.
AU - Mohammed, Faez
AU - Sibley, Paul
AU - Al-ariqi, Wadie
AU - Parveen, Ifat
N1 - Funding Information:
This project is jointly supported from Aberystwyth University and council for academics at risk (CARA). Funding: None, Competing Interests: All the authors declare that they have no conflict of interest. Ethical Approval: Not applicable
Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2022/2/8
Y1 - 2022/2/8
N2 - Rare actinomycetes are a source of numerous diverse, biologically active secondary metabolites, including macrolides, which have been shown to display several antibiotic activities. The bioactivities and representative structures of 26 groups of macrolides from rare actinomycetes are presented in this review. The most interesting groups, with a wide range of biological activities, are ammocidins, bafilomycins, neomaclafungins, rosaramicins, spinosyns, and tiacumicins. Most macrolides are from the genus, Micromonospora, with smaller contributions from genera such as Saccharothrix, Amycolatopsis, Nocardiopsis and Catenulispora. These macrolides display unique cytotoxic, antibacterial, antifungal, antimicrobial, insecticidal, anti-trypanosomal, antimalarial, antiprotozoal, antimycobacterial and anti-herpetic activity. Considering their bioactivities and diverse structures, macrolides from rare actinomycetes warrant further investigation for future applications in medicine. This work highlights the bioactivities and structures of important classes of macrolides from rare actinomycetes that are already marketed or could be used in medicine in the future.
AB - Rare actinomycetes are a source of numerous diverse, biologically active secondary metabolites, including macrolides, which have been shown to display several antibiotic activities. The bioactivities and representative structures of 26 groups of macrolides from rare actinomycetes are presented in this review. The most interesting groups, with a wide range of biological activities, are ammocidins, bafilomycins, neomaclafungins, rosaramicins, spinosyns, and tiacumicins. Most macrolides are from the genus, Micromonospora, with smaller contributions from genera such as Saccharothrix, Amycolatopsis, Nocardiopsis and Catenulispora. These macrolides display unique cytotoxic, antibacterial, antifungal, antimicrobial, insecticidal, anti-trypanosomal, antimalarial, antiprotozoal, antimycobacterial and anti-herpetic activity. Considering their bioactivities and diverse structures, macrolides from rare actinomycetes warrant further investigation for future applications in medicine. This work highlights the bioactivities and structures of important classes of macrolides from rare actinomycetes that are already marketed or could be used in medicine in the future.
KW - Antibacterial, Antifungal, Antimicrobial
KW - Cytotoxic
KW - Macrolide
KW - Rare actinomycetes
UR - http://www.scopus.com/inward/record.url?scp=85123871980&partnerID=8YFLogxK
U2 - 10.1016/j.ijantimicag.2022.106523
DO - 10.1016/j.ijantimicag.2022.106523
M3 - Review Article
C2 - 35041941
SN - 0924-8579
VL - 59
JO - International Journal of Antimicrobial Agents
JF - International Journal of Antimicrobial Agents
IS - 2
M1 - 106523
ER -